Understanding the experiences of lung volume recruitment among boys with Duchenne muscular dystrophy: A multicenter qualitative study.


Journal

Pediatric pulmonology
ISSN: 1099-0496
Titre abrégé: Pediatr Pulmonol
Pays: United States
ID NLM: 8510590

Informations de publication

Date de publication:
01 2023
Historique:
revised: 22 08 2022
received: 17 06 2022
accepted: 08 09 2022
pubmed: 15 9 2022
medline: 20 12 2022
entrez: 14 9 2022
Statut: ppublish

Résumé

Despite recommendations for regular lung volume recruitment (LVR) use in clinical practice guidelines for children with neuromuscular disease, adherence to LVR is poor. We aimed to describe the experience of LVR by boys with Duchenne muscular dystrophy (DMD), their families, and healthcare providers (HCPs), as well as to identify the barriers and facilitators to LVR use. This multicenter, qualitative study evaluated boys with DMD (n = 11) who used twice-daily LVR as part of a randomized controlled trial, as well as their parents (n = 11), and HCPs involved in the clinical use of LVR (n = 9). Semistructured interviews were conducted to identify participants' understanding of LVR therapy and their beliefs, barriers and facilitators to its use. Thematic analysis was conducted using an inductive approach. A subanalysis compared adherent and nonadherent children. Seven themes were identified related to participants' beliefs and experiences with LVR: emotional impact, adaptation to LVR, perceived benefits of LVR, routine, family engagement, clinical resources, and equipment-related factors. Strategies to improve adherence were also identified, including education, reinforcement and demonstration of LVR benefit, as well as clinician support. There were no thematic differences between adherent and nonadherent children. Despite the benefits of LVR and positive experiences with it by many families, there remain barriers to adherence to treatment. HCPs need to balance the need for early introduction to give families time to adapt to LVR while ensuring that the benefit of LVR outweighs the burden. Clinician support is important for family engagement.

Sections du résumé

BACKGROUND
Despite recommendations for regular lung volume recruitment (LVR) use in clinical practice guidelines for children with neuromuscular disease, adherence to LVR is poor. We aimed to describe the experience of LVR by boys with Duchenne muscular dystrophy (DMD), their families, and healthcare providers (HCPs), as well as to identify the barriers and facilitators to LVR use.
METHODS
This multicenter, qualitative study evaluated boys with DMD (n = 11) who used twice-daily LVR as part of a randomized controlled trial, as well as their parents (n = 11), and HCPs involved in the clinical use of LVR (n = 9). Semistructured interviews were conducted to identify participants' understanding of LVR therapy and their beliefs, barriers and facilitators to its use. Thematic analysis was conducted using an inductive approach. A subanalysis compared adherent and nonadherent children.
RESULTS
Seven themes were identified related to participants' beliefs and experiences with LVR: emotional impact, adaptation to LVR, perceived benefits of LVR, routine, family engagement, clinical resources, and equipment-related factors. Strategies to improve adherence were also identified, including education, reinforcement and demonstration of LVR benefit, as well as clinician support. There were no thematic differences between adherent and nonadherent children.
DISCUSSION
Despite the benefits of LVR and positive experiences with it by many families, there remain barriers to adherence to treatment. HCPs need to balance the need for early introduction to give families time to adapt to LVR while ensuring that the benefit of LVR outweighs the burden. Clinician support is important for family engagement.

Identifiants

pubmed: 36102618
doi: 10.1002/ppul.26154
doi:

Types de publication

Randomized Controlled Trial Multicenter Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

46-54

Informations de copyright

© 2022 Wiley Periodicals LLC.

Références

Birnkrant DJ, Bushby K, Bann CM, et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. Lancet Neurol. 2018;17(3):251-267.
Birnkrant DJ, Bushby K, Bann CM, et al. Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management. Lancet Neurol. 2018;17(4):347-361.
Sheers N, Howard ME, Berlowitz DJ. Respiratory adjuncts to NIV in neuromuscular disease. Respirology. 2019;24(6):512-520.
McKim DA, Katz SL, Barrowman N, Ni A, LeBlanc C. Lung volume recruitment slows pulmonary function decline in Duchenne muscular dystrophy. Arch Phys Med Rehabil. 2012;93(7):1117-1122.
Katz SL, Barrowman N, Monsour A, Su S, Hoey L, McKim D. Long-term effects of lung volume recruitment on maximal inspiratory capacity and vital capacity in Duchenne muscular dystrophy. Ann Am Thorac Soc. 2016;13(2):217-222.
Chiou M, Bach JR, Jethani L, Gallagher MF. Active lung volume recruitment to preserve vital capacity in Duchenne muscular dystrophy. J Rehabil Med. 2017;49(1):49-53.
O'Sullivan R, Carrier J, Cranney H, Hemming R. Effect of lung volume recruitment on pulmonary function in progressive childhood-onset neuromuscular disease: a systematic review. Arch Phys Med Rehabil. 2021;102(5):976-983.
Finder JD, Birnkrant D, Carl J, et al. Respiratory care of the patient with Duchenne muscular dystrophy: ATS consensus statement. Am J Respir Crit Care Med. 2004;170(4):456-465.
Amin R, MacLusky I, Zielinski D, et al. Pediatric home mechanical ventilation: A Canadian Thoracic Society clinical practice guideline executive summary. Can J Respir Crit Care Sleep Med. 2017;1(1):7-36.
Hull J, Aniapravan R, Chan E, et al. British Thoracic Society guideline for respiratory management of children with neuromuscular weakness. Thorax. 2012;67:i1-i40.
Katz SL, Mah JK, McMillan HJ. Routine lung volume recruitment in boys with Duchenne muscular dystrophy: a randomised clinical trial. Thorax. Published online 2022.
Sawnani H, Mayer OH, Modi AC, et al. Randomized trial of lung hyperinflation therapy in children with congenital muscular dystrophy. Pediatr Pulmonol. 2020;55(9):2471-2478.
Chatwin M, Simonds AK. Long-term mechanical insufflation-exsufflation cough assistance in neuromuscular disease: patterns of use and lessons for application. Respir Care. 2020;65(2):135-143.
Mahede T, Davis G, Rutkay A, et al. Use of mechanical airway clearance devices in the home by people with neuromuscular disorders: effects on health service use and lifestyle benefits. Orphanet J Rare Dis. 2015;10:54.
Sandelowski M. Whatever happened to qualitative description? Res Nurs Health. 2000;23(4):334-340.
Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349-357.
Guest G, Bruce A, Johnson L. How many interviews are enough? An experiment with data saturation and variability. Field Methods. 2006;18(1):59-82.
Creswell JW. Educational Research: Planning, Conducting, and Evaluating Quantitative and Qualitative Research. 4th ed. Pearson; 2012.
Atkins L, Francis J, Islam R, et al. A guide to using the Theoretical Domains Framework of behaviour change to investigate implementation problems. Implement Sci. 2017;12(1):77.
Cane J, O'Connor D, Michie S. Validation of the theoretical domains framework for use in behaviour change and implementation research. Implement Sci. 2012;7:37.
Stanojevic S, Wade A, Stocks J, et al. Reference ranges for spirometry across all ages: a new approach. Am J Respir Crit Care Med. 2008;177(3):253-260.
Naughton PE, Sheers N, Berlowitz DJ, Howard ME, McKim DA, Katz SL. Objective measurement of lung volume recruitment therapy: laboratory and clinical validation. BMJ Open Respir Res. published online July 8, 2021;8(1). doi:10.1136/bmjresp-2021-000918
Nowell L, Norris J, White D, Moules N. Thematic analysis: striving to meet the trustworthiness criteria. Int J Qual Methods. 2017;16:1-13.
Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3:77-101.
Moran FC, Spittle AJ, Delany C. Lifestyle implications of home mechanical insufflation-exsufflation for children with neuromuscular disease and their families. Respir Care. 2015;60(7):967-974.
Ennis J, Rohde K, Chaput JP, Buchholz A, Katz SL. Facilitators and barriers to noninvasive ventilation adherence in youth with nocturnal hypoventilation secondary to obesity or neuromuscular disease. J Clin Sleep Med. 2015;11(12):1409-1416.
Travlos V, Drew K, Patman S. The value of the CoughAssist® in the daily lives of children with neuromuscular disorders: experiences of families, children and physiotherapists. Dev Neurorehabil. 2016;19(5):321-326.
Pascoe JE, Sawnani H, Mayer OH, et al. Adherence and barriers to hyperinsufflation in children with congenital muscular dystrophy. Pediatr Pulmonol. 2017;52(7):939-945.
Pascoe JE, Sawnani H, Hater B, Sketch M, Modi AC. Understanding adherence to noninvasive ventilation in youth with Duchenne muscular dystrophy. Pediatr Pulmonol. 2019;54(12):2035-2043.
Hurvitz MS, Bhattacharjee R, Lesser DJ, Skalsky AJ, Orr JE. Determinants of usage and non-adherence to noninvasive ventilation in children and adults with Duchenne muscular dystrophy. J Clin Sleep Med. 2021;17(10):1973-1980.
Katz SL. Section 5: airway clearance. Can J Respir Crit Care Sleep Med. 2018;2(suppl 1):32-40.

Auteurs

Sherri L Katz (SL)

Department of Pediatrics, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada.
Children's Hospital of Eastern Ontario Research Institute, Ottawa, Ontario, Canada.
Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.

Henrietta Blinder (H)

Children's Hospital of Eastern Ontario Research Institute, Ottawa, Ontario, Canada.

Dennis Newhook (D)

Children's Hospital of Eastern Ontario Research Institute, Ottawa, Ontario, Canada.

Leana Azerrad Bmus (LA)

Children's Hospital of Eastern Ontario Research Institute, Ottawa, Ontario, Canada.

Stuart Nicholls (S)

The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.

Hugh J McMillan (HJ)

Department of Pediatrics, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada.
Children's Hospital of Eastern Ontario Research Institute, Ottawa, Ontario, Canada.
Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.

Jean K Mah (JK)

Department of Pediatrics and Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Alberta Children's Hospital Research Institute, Calgary, Alberta, Canada.
Division of Pediatric Neurology, Alberta Children's Hospital, Calgary, Alberta, Canada.

Craig Campbell (C)

Pediatrics, Epidemiology and Clinical Neurological Sciences, University of Western Ontario, London, Ontario, Canada.
Department of Paediatrics, Children's Hospital London Health Sciences Centre, London, Ontario, Canada.

Laura C McAdam (LC)

Holland Bloorview Kids Rehabilitation Hospital, Toronto, Ontario, Canada.
Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada.

David Zielinski (D)

Montreal Children's Hospital, Montreal, Quebec, Canada.
Research Institute of McGill University Health Centre, McGill University, Montreal, Quebec, Canada.

Karine Toupin-April (K)

Children's Hospital of Eastern Ontario Research Institute, Ottawa, Ontario, Canada.
Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Faculty of Health Sciences, University of Ottawa, Ottawa, Ontario, Canada.

Franco Momoli (F)

Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.

Douglas A McKim (DA)

Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
CANVent Respiratory Rehabilitation Services, The Ottawa Hospital Rehabilitation Centre, Ottawa, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH